Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy

By Paradisi G  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 542-546

Oxford University Press

Access to resources Recommend Favorite

Microvascular dysfunction in women with polycystic ovary syndrome

By Lakhani K.   Leonard A.   Seifalian A.M.   Hardiman P.  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3219-3224

Oxford University Press

Access to resources Recommend Favorite

Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of ‐cell dysfunction?

By Maliqueo M.  

Human Reproduction, Vol. 18, Iss. 12, 2003-12 ,pp. : 2683-2688

Oxford University Press

Access to resources Recommend Favorite

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

By Glueck Charles J.   Wang Ping   Goldenberg Naila   Sieve-Smith Luann  

Human Reproduction, Vol. 17, Iss. 11, 2002-11 ,pp. : 2858-2864

Oxford University Press

Access to resources Recommend Favorite

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy

By Glueck C.J.   Goldenberg N.   Wang P.   Loftspring M.   Sherman A.  

Human Reproduction, Vol. 19, Iss. 3, 2004-03 ,pp. : 510-521

Oxford University Press

Access to resources Recommend Favorite